The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Antimicrobial Peptides: An Emerging Category of Therapeutic Agents
Open accessAbstract
Antimicrobial peptides (AMPs), also known as host defense peptides, are short and generally positively charged peptides found in a wide variety of life forms from microorganisms to humans. Most AMPs have the ability to kill microbial pathogens directly, whereas others act indirectly by modulating the host defense systems. Against a background of rapidly increasing resistance development to conventional antibiotics all over the world, efforts to bring AMPs into clinical use are accelerating. Several AMPs are currently being evaluated in clinical trials as novel anti-infectives, but also as new pharmacological agents to modulate the immune response, promote wound healing, and prevent post-surgical adhesions. In this review, we provide an overview of the biological role, classification, and mode of action of AMPs, discuss the opportunities and challenges to develop these peptides for clinical applications, and review the innovative formulation strategies for application of AMPs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antimicrobial peptides of multicellular organisms
Zasloff, M. (2002) · Nature · doi:10.1038/415389a · Cited by 8,457
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
Brogden, K. A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1098 · Cited by 5,829
Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies
Hancock, R. E. W., & Sahl, H.-G. (2006) · Nature Biotechnology · doi:10.1038/nbt1267 · Cited by 4,208
Atopic Dermatitis: Global Epidemiology and Risk Factors
Nutten, S. (2015) · Annals of Nutrition and Metabolism · doi:10.1159/000370220 · Cited by 3,055
Mechanisms of Antimicrobial Peptide Action and Resistance
Yeaman, M. R., & Yount, N. Y. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.1.2 · Cited by 3,001
Jenssen, H., Hamill, P., & Hancock, R. E. W. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00056-05 · Cited by 2,518
Mesoporous Materials for Drug Delivery
Vallet‐Regí, M., Balas, F., & Arcos, D. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200604488 · Cited by 2,507
Designing antimicrobial peptides: form follows function
Fjell, C. D., Hiss, J. A., Hancock, R. E. W., & Schneider, G. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3591 · Cited by 2,035
Endogenous Antimicrobial Peptides and Skin Infections in Atopic Dermatitis
Ong, P. Y., Ohtake, T., Brandt, C., Strickland, I., Boguniewicz, M., Ganz, T., Gallo, R. L., & Leung, D. Y. M. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021481 · Cited by 1,960
Falagas, M. E., Kasiakou, S. K., & Saravolatz, L. D. (2005) · Clinical Infectious Diseases · doi:10.1086/429323 · Cited by 1,744
Peptide Antibiotics and Their Role in Innate Immunity
Boman, H. (1995) · Annual Review of Immunology · doi:10.1146/annurev.immunol.13.1.61 · Cited by 1,665
Cutting Edge: 1,25-Dihydroxyvitamin D3 Is a Direct Inducer of Antimicrobial Peptide Gene Expression
Wang, T.-T., Nestel, F. P., Bourdeau, V., Nagai, Y., Wang, Q., Liao, J., Tavera-Mendoza, L., Lin, R., Hanrahan, J. W., Mader, S., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.2909 · Cited by 1,637
The expanding scope of antimicrobial peptide structures and their modes of action
Nguyen, L. T., Haney, E. F., & Vogel, H. J. (2011) · Trends in Biotechnology · doi:10.1016/j.tibtech.2011.05.001 · Cited by 1,604
Synthetic therapeutic peptides: science and market
Vlieghe, P., Lisowski, V., Martinez, J., & Khrestchatisky, M. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2009.10.009 · Cited by 1,476
Diversity of antimicrobial peptides and their mechanisms of action
Epand, R. M., & Vogel, H. J. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00198-4 · Cited by 1,358
AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense
Lai, Y., & Gallo, R. L. (2009) · Trends in Immunology · doi:10.1016/j.it.2008.12.003 · Cited by 1,276
The role of cationic antimicrobial peptides in innate host defences
Hancock, R. E. W., & Diamond, G. (2000) · Trends in Microbiology · doi:10.1016/s0966-842x(00)01823-0 · Cited by 1,218
Innate antimicrobial peptide protects the skin from invasive bacterial infection
Nizet, V., Ohtake, T., Lauth, X., Trowbridge, J., Rudisill, J., Dorschner, R. A., Pestonjamasp, V., Piraino, J., Huttner, K., & Gallo, R. L. (2001) · Nature · doi:10.1038/35106587 · Cited by 1,198
Hancock, R. E. W., & Chapple, D. S. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.6.1317 · Cited by 1,190
Hancock, R. E. (1997) · The Lancet · doi:10.1016/s0140-6736(97)80051-7 · Cited by 1,096
Human β-Defensin-1 Is a Salt-Sensitive Antibiotic in Lung That Is Inactivated in Cystic Fibrosis
Goldman, M. J., Anderson, G. M., Stolzenberg, E. D., Kari, U. P., Zasloff, M., & Wilson, J. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81895-4 · Cited by 1,080
Antimicrobial peptides: premises and promises
Reddy, K. V. R., Yedery, R. D., & Aranha, C. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.09.005 · Cited by 1,068
The co-evolution of host cationic antimicrobial peptides and microbial resistance
Peschel, A., & Sahl, H.-G. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1441 · Cited by 1,062
Antibacterial peptides for therapeutic use: obstacles and realistic outlook
MARR, A., GOODERHAM, W., & HANCOCK, R. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.04.006 · Cited by 1,051
The relationship between peptide structure and antibacterial activity
Powers, J.-P. S., & Hancock, R. E. W. (2003) · Peptides · doi:10.1016/j.peptides.2003.08.023 · Cited by 948
Development of Nanoparticles for Antimicrobial Drug Delivery
Zhang, L., Pornpattananangkul, D., Hu, C.-M., & Huang, C.-M. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790416290 · Cited by 886
Alternatives to antibiotics—a pipeline portfolio review
Czaplewski, L., Bax, R., Clokie, M., Dawson, M., Fairhead, H., Fischetti, V. A., Foster, S., Gilmore, B. F., Hancock, R. E. W., Harper, D., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00466-1 · Cited by 848
Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review
Zavascki, A. P., Goldani, L. Z., Li, J., & Nation, R. L. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm357 · Cited by 834
Toxicity of polymyxins: a systematic review of the evidence from old and recent studies
Falagas, M. E., & Kasiakou, S. K. (2006) · Critical Care · doi:10.1186/cc3995 · Cited by 828
Antimicrobial peptides: key components of the innate immune system
Pasupuleti, M., Schmidtchen, A., & Malmsten, M. (2012) · Critical Reviews in Biotechnology · doi:10.3109/07388551.2011.594423 · Cited by 799
Mechanisms and consequences of bacterial resistance to antimicrobial peptides
Andersson, D. I., Hughes, D., & Kubicek-Sutherland, J. Z. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.04.002 · Cited by 715
Control of cell selectivity of antimicrobial peptides
Matsuzaki, K. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.09.013 · Cited by 713
The Human Antimicrobial Peptide LL-37 Is a Multifunctional Modulator of Innate Immune Responses
Scott, M. G., Davidson, D. J., Gold, M. R., Bowdish, D., & Hancock, R. E. W. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.7.3883 · Cited by 713
Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus
Mygind, P. H., Fischer, R. L., Schnorr, K. M., Hansen, M. T., Sönksen, C. P., Ludvigsen, S., Raventós, D., Buskov, S., Christensen, B., De Maria, L., et al. (2005) · Nature · doi:10.1038/nature04051 · Cited by 657
Multifunctional cationic host defence peptides and their clinical applications
Yeung, A. T. Y., Gellatly, S. L., & Hancock, R. E. W. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0710-x · Cited by 610
Antimicrobial peptides: an overview of a promising class of therapeutics
Giuliani, A., Pirri, G., & Nicoletto, S. (2007) · Open Life Sciences · doi:10.2478/s11535-007-0010-5 · Cited by 606
Large-scale manufacture of peptide therapeutics by chemical synthesis
Bray, B. L. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1133 · Cited by 598
Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung.
Bals, R., Wang, X., Wu, Z., Freeman, T., Bafna, V, Zasloff, M., & Wilson, J. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2410 · Cited by 577
Dorschner, R. A., Pestonjamasp, V. K., Tamakuwala, S., Ohtake, T., Rudisill, J., Nizet, V., Agerberth, B., Gudmundsson, G. H., & Gallo, R. L. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2001.01340.x · Cited by 567
Mookherjee, N., Brown, K. L., Bowdish, D. M. E., Doria, S., Falsafi, R., Hokamp, K., Roche, F. M., Mu, R., Doho, G. H., Pistolic, J., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.4.2455 · Cited by 567
Landman, D., Georgescu, C., Martin, D. A., & Quale, J. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00006-08 · Cited by 565
Chertov, O., Michiel, D. F., Xu, L., Wang, J. M., Tani, K., Murphy, W. J., Longo, D. L., Taub, D. D., & Oppenheim, J. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.6.2935 · Cited by 548
Modulating immunity as a therapy for bacterial infections
Hancock, R. E. W., Nijnik, A., & Philpott, D. J. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2745 · Cited by 535
Antimicrobial peptides stage a comeback
Fox, J. L. (2013) · Nature Biotechnology · doi:10.1038/nbt.2572 · Cited by 524
Epithelial antimicrobial peptides in host defense against infection
Bals, R. (2000) · Respiratory Research · doi:10.1186/rr25 · Cited by 498
Methods and Protocols of Modern Solid Phase Peptide Synthesis
Amblard, M., Fehrentz, J.-A., Martinez, J., & Subra, G. (2006) · Molecular Biotechnology · doi:10.1385/mb:33:3:239 · Cited by 497
Davidson, D. J., Currie, A. J., Reid, G. S. D., Bowdish, D. M. E., MacDonald, K. L., Ma, R. C., Hancock, R. E. W., & Speert, D. P. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.2.1146 · Cited by 429
Engineered Endolysin-Based “Artilysins” To Combat Multidrug-Resistant Gram-Negative Pathogens
Briers, Y., Walmagh, M., Van Puyenbroeck, V., Cornelissen, A., Cenens, W., Aertsen, A., Oliveira, H., Azeredo, J., Verween, G., Pirnay, J.-P., et al. (2014) · mBio · doi:10.1128/mbio.01379-14 · Cited by 421
Lactoferrin: Lactoferrin: a modulator of immune and inflammatory responses
Legrand, D., Elass, E., Carpentier, M., & Mazurier, J. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5370-2 · Cited by 420
Hassan, M., Kjos, M., Nes, I. F., Diep, D. B., & Lotfipour, F. (2012) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2012.05338.x · Cited by 402
Effect of Divalent Cation Removal on the Structure of Gram-Negative Bacterial Outer Membrane Models
Clifton, L. A., Skoda, M. W. A., Le Brun, A. P., Ciesielski, F., Kuzmenko, I., Holt, S. A., & Lakey, J. H. (2015) · Langmuir · doi:10.1021/la504407v · Cited by 389
Complicated skin and soft tissue infection
Dryden, M. S. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq302 · Cited by 366
Tokumaru, S., Sayama, K., Shirakata, Y., Komatsuzawa, H., Ouhara, K., Hanakawa, Y., Yahata, Y., Dai, X., Tohyama, M., Nagai, H., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.7.4662 · Cited by 358
Zhang, L., Dhillon, P., Yan, H., Farmer, S., & Hancock, R. E. W. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3317-3321.2000 · Cited by 349
Lactoferrin down-regulates the LPS-induced cytokine production in monocytic cells via NF-κB
Håversen, L., Ohlsson, B. G., Hahn-Zoric, M., Hanson, L. Å., & Mattsby-Baltzer, I. (2002) · Cellular Immunology · doi:10.1016/s0008-8749(03)00006-6 · Cited by 336
Takahashi, D., Shukla, S. K., Prakash, O., & Zhang, G. (2010) · Biochimie · doi:10.1016/j.biochi.2010.02.023 · Cited by 331
Discovering and improving novel peptide therapeutics
MCGREGOR, D. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.06.002 · Cited by 331
Lipsky, B. A., Holroyd, K. J., & Zasloff, M. (2008) · Clinical Infectious Diseases · doi:10.1086/593185 · Cited by 324
Antimicrobial peptides: New candidates in the fight against bacterial infections
Toke, O. (2005) · Peptide Science · doi:10.1002/bip.20286 · Cited by 322
Yamshchikov, A. V., Desai, N. S., Blumberg, H. M., Ziegler, T. R., & Tangpricha, V. (2009) · Endocrine Practice · doi:10.4158/ep09101.orr · Cited by 307
Advances in antimicrobial peptide immunobiology
Yount, N. Y., Bayer, A. S., Xiong, Y. Q., & Yeaman, M. R. (2006) · Peptide Science · doi:10.1002/bip.20543 · Cited by 278
Human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure
Shaykhiev, R., Beißwenger, C., Kändler, K., Senske, J., Püchner, A., Damm, T., Behr, J., & Bals, R. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00286.2004 · Cited by 254
Vitamin D Induces the Antimicrobial Protein hCAP18 in Human Skin
Weber, G., Heilborn, J. D., Chamorro Jimenez, C. I., Hammarsjö, A., Törmä, H., & Ståhle, M. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23687.x · Cited by 253
Ciornei, C. D., Sigurdardóttir, T., Schmidtchen, A., & Bodelsson, M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.2845-2850.2005 · Cited by 247
Niyonsaba, F., Ushio, H., Nagaoka, I., Okumura, K., & Ogawa, H. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.3.1776 · Cited by 246
Antimicrobial Peptides: Their Role as Infection-Selective Tracers for Molecular Imaging
Ebenhan, T., Gheysens, O., Kruger, H. G., Zeevaart, J. R., & Sathekge, M. M. (2014) · BioMed Research International · doi:10.1155/2014/867381 · Cited by 225
Road to Clinical Efficacy: Challenges and Novel Strategies for Antimicrobial Peptide Development
Eckert, R. (2011) · Future Microbiology · doi:10.2217/fmb.11.27 · Cited by 204
Briers, Y., Walmagh, M., Grymonprez, B., Biebl, M., Pirnay, J.-P., Defraine, V., Michiels, J., Cenens, W., Aertsen, A., Miller, S., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02668-14 · Cited by 200
Grönberg, A., Mahlapuu, M., Ståhle, M., Whately‐Smith, C., & Rollman, O. (2014) · Wound Repair and Regeneration · doi:10.1111/wrr.12211 · Cited by 191
Self-citationBriers, Y., & Lavigne, R. (2015) · Future Microbiology · doi:10.2217/fmb.15.8 · Cited by 189
Mattsby-Baltzer, I., Roseanu, A., Motas, C., Elverfors, J., Engberg, I., & Hanson, L. Å. (1996) · Pediatric Research · doi:10.1203/00006450-199608000-00011 · Cited by 189
Membrane interactions of mesoporous silica nanoparticles as carriers of antimicrobial peptides
Braun, K., Pochert, A., Lindén, M., Davoudi, M., Schmidtchen, A., Nordström, R., & Malmsten, M. (2016) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2016.05.002 · Cited by 188
Improved Methods for Classification, Prediction, and Design of Antimicrobial Peptides
Wang, G. (2015) · Methods in Molecular Biology · doi:10.1007/978-1-4939-2285-7_3 · Cited by 187
The mammalian ionic environment dictates microbial susceptibility to antimicrobial defense peptides
Dorschner, R. A., Lopez‐Garcia, B., Peschel, A., Kraus, D., Morikawa, K., Nizet, V., & Gallo, R. L. (2006) · The FASEB Journal · doi:10.1096/fj.05-4406com · Cited by 186
Cationic antimicrobial peptides: towards clinical applications
Hancock, R. E. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.8.1723 · Cited by 176
Brinckerhoff, L. H., Kalashnikov, V. V., Thompson, L. W., Yamshchikov, G. V., Pierce, R. A., Galavotti, H. S., Engelhard, V. H., & Slingluff, C. L. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19991029)83:3<326::aid-ijc7>3.0.co;2-x · Cited by 172
Antimicrobial peptides (AMPs) as drug candidates: a patent review (2003–2015)
Kosikowska, P., & Lesner, A. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2016.1176149 · Cited by 165
Antimicrobial and antiviral hydrogels
Malmsten, M. (2011) · Soft Matter · doi:10.1039/c1sm05809f · Cited by 164
Efficacy of Artilysin Art-175 against Resistant and Persistent Acinetobacter baumannii
Defraine, V., Schuermans, J., Grymonprez, B., Govers, S. K., Aertsen, A., Fauvart, M., Michiels, J. J., Lavigne, R., & Briers, Y. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00285-16 · Cited by 160
To protect peptide pharmaceuticals against peptidases
Rink, R., Arkema-Meter, A., Baudoin, I., Post, E., Kuipers, A., Nelemans, S. A., Akanbi, M. H. J., & Moll, G. N. (2010) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2010.02.010 · Cited by 153
d’Angelo, I., Casciaro, B., Miro, A., Quaglia, F., Mangoni, M. L., & Ungaro, F. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.08.027 · Cited by 152
Incorporation of antimicrobial compounds in mesoporous silica film monolith
Izquierdo‐Barba, I., Vallet‐Regí, M., Kupferschmidt, N., Terasaki, O., Schmidtchen, A., & Malmsten, M. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.07.003 · Cited by 133
Rivas-Santiago, B. T., Rivas-Santiago, C., Castañeda‐Delgado, J. E., León‐Contreras, J. C., Hancock, R. E. W., & Hernández‐Pando, R. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.09.015 · Cited by 130
Organization and function of anionic phospholipids in bacteria
Lin, T., & Weibel, D. B. (2016) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-016-7468-x · Cited by 128
Safety and tolerability of the antimicrobial peptide human lactoferrin 1-11 (hLF1-11)
van der Velden, W. J. F. M., van Iersel, T. M., Blijlevens, N. M. A., & Donnelly, J. P. (2009) · BMC Medicine · doi:10.1186/1741-7015-7-44 · Cited by 119
Lamb, H. M., & Wiseman, L. R. (1998) · Drugs · doi:10.2165/00003495-199856060-00011 · Cited by 108
Nilsson, A. C., Janson, H., Wold, H., Fugelli, A., Andersson, K., Håkangård, C., Olsson, P., & Olsen, W. M. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03513-14 · Cited by 103
Hunter, H. N., Demcoe, A. R., Jenssen, H., Gutteberg, T. J., & Vogel, H. J. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3387-3395.2005 · Cited by 99
Highly Selective End-Tagged Antimicrobial Peptides Derived from PRELP
Malmsten, M., Kasetty, G., Pasupuleti, M., Alenfall, J., & Schmidtchen, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016400 · Cited by 88
van der Does, A. M., Bogaards, S. J. P., Ravensbergen, B., Beekhuizen, H., van Dissel, J. T., & Nibbering, P. H. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00652-09 · Cited by 78
Mechanism and Fitness Costs of PR-39 Resistance in Salmonella enterica Serovar Typhimurium LT2
Pränting, M., Negrea, A., Rhen, M., & Andersson, D. I. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00205-08 · Cited by 76
Recent advances in topical delivery of proteins and peptides mediated by soft matter nanocarriers
Witting, M., Obst, K., Frieß, W., & Hedtrich, S. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.01.010 · Cited by 70
Tomenius, H. L., Pränting, M., Thulin, E., & Andersson, D. I. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068875 · Cited by 66
Umerska, A. M., Cassisa, V., Matougui, N., Joly‐Guillou, M., Eveillard, M., & Saulnier, P. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.09.001 · Cited by 66
Solid Phase Protein Chemical Synthesis
Raibaut, L., Mahdi, O. E., & Melnyk, O. (2014) · Topics in current chemistry · doi:10.1007/128_2014_609 · Cited by 64
Maiti, S., Patro, S., Purohit, S., Jain, S., Senapati, S., & Dey, N. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03628-14 · Cited by 56
Wiig, M. E., Dahlin, L. B., Fridén, J. O., Hagberg, L., Larsen, S. E., Wiklund, K., & Mahlapuu, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110735 · Cited by 55
Self-citationPerspectives on Polymeric Nanostructures for the Therapeutic Application of Antimicrobial Peptides
Sandreschi, S., Piras, A. M., Batoni, G., & Chiellini, E. (2016) · Nanomedicine · doi:10.2217/nnm-2016-0057 · Cited by 53
Rodríguez–Martínez, S., Cancino‐Díaz, J. C., Vargas‐Zuñiga, L. M., & Cancino-Diaz, M. E. (2008) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2008.03340.x · Cited by 49
Nilsson, E., Björn, C., Sjöstrand, V., Lindgren, K., Münnich, M., Mattsby‐Baltzer, I., Ivarsson, M., Olmarker, K., & Mahlapuu, M. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181b246a7 · Cited by 33
Self-citationBjörn, C., Håkansson, J., Myhrman, E., Sjöstrand, V., Haug, T., Lindgren, K., Blencke, H., Stensvåg, K., & Mahlapuu, M. (2012) · AMB Express · doi:10.1186/2191-0855-2-67 · Cited by 32
Self-citationEdsfeldt, S., Holm, B., Mahlapuu, M., Reno, C. R., Hart, D. A., & Wiig, M. E. (2016) · Upsala Journal of Medical Sciences · doi:10.1080/03009734.2016.1230157 · Cited by 29
Self-citation
Cited by
Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review
Mulani, M. S., Kamble, E. E., Kumkar, S. N., Tawre, M. S., & Pardesi, K. R. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00539 · Cited by 1,644
Antimicrobial peptides: mechanism of action, activity and clinical potential
Zhang, Q.-Y., Yan, Z.-B., Meng, Y.-M., Hong, X.-Y., Shao, G., Ma, J.-J., Cheng, X.-R., Liu, J., Kang, J., & Fu, C.-Y. (2021) · Military Medical Research · doi:10.1186/s40779-021-00343-2 · Cited by 1,065
A Comprehensive Review on Current Advances in Peptide Drug Development and Design
Lee, A. C.-L., Harris, J. L., Khanna, K. K., & Hong, J.-H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102383 · Cited by 686
Alternatives to Conventional Antibiotics in the Era of Antimicrobial Resistance
Ghosh, C., Sarkar, P., Issa, R., & Haldar, J. (2019) · Trends in Microbiology · doi:10.1016/j.tim.2018.12.010 · Cited by 661
Development and Challenges of Antimicrobial Peptides for Therapeutic Applications
Chen, C. H., & Lu, T. K. (2020) · Antibiotics · doi:10.3390/antibiotics9010024 · Cited by 598
Metadata
- Authors
- Mahlapuu, M., Håkansson, J., Ringstad, L., & Björn, C.
- Venue
- Frontiers in Cellular and Infection Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2016-12-27
- Volume
- 6
- Pages
- 194-194
- ISSN
- 2235-2988 (ISSN-L)
- OpenAlex
- W2562261325
- Cited by
- 1,927
- References
- 102
- FWCI
- 88.25
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.